Stephen J. Greene, MD, Michael Bohm, MD, Biykem Bozkurt, MD, PhD., Javed Butler, MD, MPH, MBA., John G.F. Cleland, MD., PhD., Andrew J.S. Coats, MD., Nihar R. Desai, MD, MPH., Diederick E. Grobbee, MD., PhD., Ellie Kelepouris, MD, Fausto Pinto, Md., PhD., Giuseppe Rosano, MD, PhD., Isabelle Morin, MSc., et. al Cardiovascular and Renal Treatment in Heart Failure Patients with Hyperkalemia or High Risk of Hyperkalemia: Rational and Design of the CARE-HK in HF Registry , Journal of Cardiac Failure, 31(6): 2025,881-891

Quinn, G., Greene, S, Sauer, A., Anker, S.D., Bohm, M., Bozkurt, B., Butler, J., Cleland, J.G., Coats, A.J.S., Desai, N., Pinto, F., Rosano, G., Brandes, C, M, Donachie, V., Kelepouris, E. Optimisation of renin-angiotensin-aldosterone system inhibitors use in chronic kidney disease patients with heart failure: is hyperkalemia barrier? , European Society of Cardiology: Heart Failure Association. Belgrade, Serbia: 2025,16-20

Martinez, O.C., Greene, S., Anker, S, Bozkurt, B, Butler, J., Cleland, J.G., Desai, N, Grobbee, D, Kelepouris, E. Rosano, G, Brandes, C.M., Donachie, V, Sauer, A. Real-world use and effectiveness of patiromer among patients with heart failure at high risk of hyperkalemia: insights from the CARE-HK in HF registry , European Heart Failure Association - Belgrade, Serbia: 2025

G. Quinn, S.J. Greene, A.J. Sauer, S.D. Anker, M. Bloom, B. Bozkurt, J. Butler, J.G.F. Cleland, A.J.S. Coats, N.R. Desai, F. Pinto, G. Rosano, Brandes, C-M, V. Donachie and Kelepouris, E. Optimisation of renin-angiotensin-aldosterone system inhibitors use in chronic kidney disease patients with heart failure: is hyperkalemia a barrier? , European Heart Failure Association, Belgrade, Serbia: 2025

Kelepouris, E., Desai, N., Kosirobod, M., Budden, J., Boehm, M. Collaborative Management o Hyperkalemia in Patients with Complex Heart Failure. , Case Reports in Nephrology and Dialysis, Case Reports: 2025

Martinez, O.C., Greene, S., Anker, S., Bozkurt, B., Butler, J., Cleland, J.G., Desai, N., Grobbee, D., Kelepouris, E., Rosano, G., Brandes, C.M., Donachie, V., Sauer, A. Real-world use and effectiveness of patiromer among patients with heart failure at high risk of hyperkalemia: insights from the CARE-HK in HF registry , EHA: 2025

E. Kelepouris, N. Desai, K.A.A. Clark, M.N. Kosiborod, J. Budden, S. Waechter, and M. Bohm Collaborative management of hyperkalemia in patients with complex heart failure , Journal Case Reports in Nephrology and Dialysis: 2024

Rastogi A, Chertow GM, Collins A, Kelepouris E, Kotzker W, Middleton JP, Rajpal M, Roy-Chaudhury P. Utilization of Potassium Binders for the Management of Hyperkalemia in Chronic Kidney Disease: A Position Statement by US Nephrologists , Adv Kidney Dis Health, 31(6): 2024,514-522

A. Rastogi, A. Collins, E. Kelepouris, W. Kotzker, J.P. Middleton, M. Rajpal, P. Roy-Chaudhury and G.M. Chertow Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists , Journal of Primary Care and Community Health , 15: 2024,21501319241259905

S.J. Greene, M. Bohn, B. Bozkurt, J. Butler, J.G.F. Cleland, A.J.S. Coats, N.R. Desai, D.E.Grobbee, E. Kelepouris, F. Pinto, G. Rosano, I. Morin, P. Szecsody, S. Fabien, S. Waechter, M.G. Crespo-Leiro, M. Hulsmann, T. Kempf, O. Pfister, A-C Pouleur, A.J. Sauer, M. Saxena, M. Schulz, M. Volterrani, S.D. Anker and M. Kosiborod Cardiovascular and Renal Treatment in Heart Failure Patients with Hyperkalemia or high risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry , J. of Cardiac Failure, 00: 2024,1-11